FN1, fibronectin 1, 2335

N. diseases: 724; N. variants: 33
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0025202
Disease: melanoma
melanoma
0.100 Biomarker disease BEFREE Fibronectin 1 promotes melanoma proliferation and metastasis by inhibiting apoptosis and regulating EMT. 31118673 2019
CUI: C0025202
Disease: melanoma
melanoma
0.100 AlteredExpression disease BEFREE Its re-expression inhibited melanoma growth and metastasis and reduced the deposition of fibronectin, a major ECM component. 29450192 2018
CUI: C0025202
Disease: melanoma
melanoma
0.100 AlteredExpression disease BEFREE Rebuilding of melanoma into the fibrous tissue during SR was connected with a general rise in fibronectin and tenascin C expression. 30061229 2018
CUI: C0025202
Disease: melanoma
melanoma
0.100 Biomarker disease BEFREE Fibronectin is a large multidomain protein of the extracellular matrix that harbors two heparin binding sites, Hep-I and Hep-II, which support the heparin-dependent adhesion of melanoma and neuroblastoma cells [Barkalow, F. J. 30260627 2018
CUI: C0025202
Disease: melanoma
melanoma
0.100 Biomarker disease BEFREE Human melanoma inhibitory protein binds to the FN12-14 Hep II domain of fibronectin. 28565914 2017
CUI: C0025202
Disease: melanoma
melanoma
0.100 Biomarker disease BEFREE BCP inhibited integrin-mediated adhesion of human melanoma A375 cells to fibronectin but had no effects on nonspecific adhesion to poly-l-lysine. 27842819 2017
CUI: C0025202
Disease: melanoma
melanoma
0.100 AlteredExpression disease BEFREE Analysis of a melanoma tissue microarray showed loss of PTEN expression to predict for a lower overall survival, with a trend for even lower survival being seen when loss of fibronectin was included in the analysis. 26073081 2016
CUI: C0025202
Disease: melanoma
melanoma
0.100 Biomarker disease BEFREE Whereas the role of TNC (tenascin C) and FN1 (fibronectin 1) in melanoma development is well documented, implication of MARCKS, RCN3, BAMBI, PEA3/ETV4 and the FK506 family members FKBP7, FKBP10 and FKBP11 in melanoma progression is unclear. 27689402 2016
CUI: C0025202
Disease: melanoma
melanoma
0.100 Biomarker disease BEFREE Melanoma cell adhesion to fibronectin in the presence of Sambucus nigra agglutinin (SNA) was reduced only in IGR-39 and WM266-4 cells, whereas the impact of Maackia amurensis agglutinin (MAA) on this process was much more important. 27474400 2016
CUI: C0025202
Disease: melanoma
melanoma
0.100 Biomarker disease BEFREE Herein, we report a novel mechanism through which NME1 controls melanoma cell morphology via upregulation of the extracellular matrix (ECM) protein fibronectin. 25808322 2015
CUI: C0025202
Disease: melanoma
melanoma
0.100 AlteredExpression disease BEFREE Forced NME1 expression in a variety of melanoma-derived cell lines was shown to induce dynamic changes in cell morphology and reorganization of the actin cytoskeleton, with formation of a network of thick stress fibers and assembly of fibronectin fibrils at large focal adhesions. 25017017 2015
CUI: C0025202
Disease: melanoma
melanoma
0.100 Biomarker disease BEFREE CH50, a recombinant CBD-HepII polypeptide of human fibronectin, was shown to suppress tumor metastasis in murine hepatocarcinoma and melanoma models. 24288120 2014
CUI: C0025202
Disease: melanoma
melanoma
0.100 Biomarker disease BEFREE Here, we showed that lipid rafts played a critical role in human melanoma A375 cell spreading and migration on fibronectin; an important component of the ECM that interacts with β1 integrin. 24292944 2013
CUI: C0025202
Disease: melanoma
melanoma
0.100 Biomarker disease BEFREE Of the genes identified, seven genes: galectin 3 (Lgals3), melanoma cell adhesion molecule (Mcam), fibronectin 1 (Fn1), signal transducer and activator of transcription 3 (Stat3), microphthalmia-associated transcription factor (Mitf), max interacting protein 1 (Max1), and non-metastatic cells 1, protein (NM23A) expressed in (Nme1) are known to be associated with melanoma, but have not yet been reported as being regulated by hypoxia in human melanoma cells. 21912348 2011
CUI: C0025202
Disease: melanoma
melanoma
0.100 AlteredExpression disease BEFREE The reduced ability of M5 cells to adhere onto the fibronectin (FN) substrate was directly correlated to a decrease in the expression of focal adhesion kinase (FAK), which is a key regulator of melanoma motility. 21360640 2011
CUI: C0025202
Disease: melanoma
melanoma
0.100 Biomarker disease BEFREE Together, these data support the notion that BH3 mimetic compounds that target Mcl-1 may be effective for the treatment of melanoma in combinatorial strategies with agents that disrupt fibronectin-integrin signaling. 19372583 2009
CUI: C0025202
Disease: melanoma
melanoma
0.100 Biomarker disease BEFREE The reduction in syndecan-4 expression by utilizing specific siRNA discriminately increased melanoma cell motility and decreased their attachment on FN, demonstrating a regulatory role of syndecan-4 on these cell functions. 19110070 2009
CUI: C0025202
Disease: melanoma
melanoma
0.100 Biomarker disease BEFREE Most importantly, siRNA-downregulation of hB7H3 reduced cell adhesion to fibronectin of melanoma and breast cancer cells by up to 50 %, and migration and matrigel-invasion by more than 70 %, but surprisingly had no apparent impact on cell proliferation. 18690846 2008
CUI: C0025202
Disease: melanoma
melanoma
0.100 Biomarker disease BEFREE These results reveal a tumor-specific regulation of fibronectin by constitutive ERK/MAP kinase signaling and indicate that self-production of fibronectin may play a role in melanoma tumorigenesis, by promoting tumor cell invasion. 16960555 2007
CUI: C0025202
Disease: melanoma
melanoma
0.100 Biomarker disease BEFREE Secreted trbeta3 inhibited adhesion of melanoma and prostate cancer cells to fibronectin and vitronectin, which was partially reversed by adsorption of trbeta3 from the media. 17912026 2007
CUI: C0025202
Disease: melanoma
melanoma
0.100 Biomarker disease BEFREE Our DNA microarray analyses of benign nevi and melanoma tissue specimens revealed that the genes encoding extracellular matrix proteins tenascin-C (TN-C), fibronectin (FN), and procollagen-I (PCOL-I) are highly upregulated in invasive and metastatic melanomas. 16924594 2006
CUI: C0025202
Disease: melanoma
melanoma
0.100 Biomarker disease LHGDN Role of the extracellular matrix proteins in the resistance of SP6.5 uveal melanoma cells toward cisplatin. 15645125 2005
CUI: C0025202
Disease: melanoma
melanoma
0.100 Biomarker disease BEFREE Increased fibronectin synthesis has been associated with the metastatic potential of melanoma cells; however, the molecular mechanisms underlying fibronectin overexpression during melanoma development are poorly understood. 15608673 2005
CUI: C0025202
Disease: melanoma
melanoma
0.100 AlteredExpression disease BEFREE The purpose of the present study was to investigate the expression of integrin subunit alpha5, its corresponding ligand fibronectin (FN), and the expression pattern for MMPs in four highly proliferative human choroidal melanomas (TP17, TP31, SP8.0, and SP6.5) to evaluate whether any correlation can be established between these markers and cell tumorigenicity. 10892885 2000
CUI: C0025202
Disease: melanoma
melanoma
0.100 AlteredExpression disease BEFREE Our data indicate that FN is able to modulate expression and secretion of a defined subset of lymphokines in human melanoma. 8608953 1996